Compare ALUR & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALUR | TRIB |
|---|---|---|
| Founded | 2009 | 1992 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9M | 18.6M |
| IPO Year | N/A | N/A |
| Metric | ALUR | TRIB |
|---|---|---|
| Price | $1.48 | $0.91 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.25 | N/A |
| AVG Volume (30 Days) | 109.6K | ★ 404.6K |
| Earning Date | 11-12-2025 | 02-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $17,208,000.00 | ★ $48,570,000.00 |
| Revenue This Year | N/A | $13.51 |
| Revenue Next Year | $15.47 | $13.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.02 | $0.48 |
| 52 Week High | $7.40 | $3.44 |
| Indicator | ALUR | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 46.78 | 57.12 |
| Support Level | $1.28 | $0.66 |
| Resistance Level | $1.57 | $0.95 |
| Average True Range (ATR) | 0.16 | 0.06 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 32.31 | 87.12 |
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.